MARVIG Trademark

Trademark Overview

On Tuesday, July 29, 2014, a trademark application was filed for MARVIG with the United States Patent and Trademark Office. The USPTO has given the MARVIG trademark a serial number of 79151625. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, July 29, 2024. This trademark is owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED. The MARVIG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely blood derivatives, namely immunoglobulins
marvig

General Information

Serial Number79151625
Word MarkMARVIG
Filing DateTuesday, July 29, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, July 29, 2024
Registration Number4697805
Registration DateTuesday, March 10, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely blood derivatives, namely immunoglobulins

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGRIFOLS WORLDWIDE OPERATIONS LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIE
Party NameGRIFOLS WORLDWIDE OPERATIONS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIE
Party NameGRIFOLS WORLDWIDE OPERATIONS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIE

Trademark Events

Event DateEvent Description
Saturday, September 13, 2014APPLICATION FILING RECEIPT MAILED
Thursday, September 4, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, September 8, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, September 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 12, 2014ASSIGNED TO EXAMINER
Wednesday, December 3, 2014NOTICE OF PUBLICATION
Wednesday, December 3, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 3, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, December 19, 2014NOTIFICATION PROCESSED BY IB
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, April 9, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 19, 2015FINAL DISPOSITION PROCESSED
Tuesday, May 19, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 5, 2015NOTIFICATION PROCESSED BY IB
Friday, October 30, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, September 13, 2018NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 26, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 16, 2022INVALIDATION PROCESSED
Friday, November 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 26, 2021CANCELLED SECTION 71
Friday, February 21, 2025DEATH OF INTERNATIONAL REGISTRATION
Monday, October 17, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, September 16, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

marvig namely immunoglobulins derivatives blood pharmaceutical preparations